Blaser Brian J.
Blaser Brian J.'s purchase track record
How the stock did after each of Blaser Brian J.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/13/2026 | QDEL | $249K | -56.2% | -39.4% | +13.9% |
| 11/19/2025 | QDEL | $502K | +15.1% | -43.3% | +11.9% |
| 12/11/2024 | QDEL | $250K | -11.2% | -25.4% | -1.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Quanterix Highlights Spatial Biology Innovation at ESSB 2026. Quanterix announced it met its spatial biology content innovation commitments during the ESSB 2026 event. The company showcased new tools and data sets that support advanced spatial analysis. This demonstrates progress in its product roadmap and may strengthen its position in the spatial biology market.
Transaction History
| QDEL | ▲ Buy | Grant | 20,759 | $0 | 5/15/2026 | View on chart |
| QDEL | ▼ Sell | Tax Withholding | 10,252 | $106K | 5/15/2026 | View on chart |
| QDEL | ▲ Buy | Open Market | 10,540 | $249K | 2/13/2026 | View on chart |
| QDEL | ▲ Buy | Grant | 21,446 | $0 | 1/29/2026 | View on chart |
| QDEL | ▼ Sell | Tax Withholding | 7,755 | $213K | 1/29/2026 | View on chart |
| QDEL | ▲ Buy | Open Market | 23,500 | $502K | 11/19/2025 | View on chart |
| QDEL | ▲ Buy | Grant | 20,759 | $0 | 5/15/2025 | View on chart |
| QDEL | ▼ Sell | Tax Withholding | 9,308 | $307K | 5/15/2025 | View on chart |
| QDEL | ▲ Buy | Open Market | 6,033 | $250K | 12/11/2024 | View on chart |
| QTRX | ▲ Buy | Grant | 2,947 | $0 | 1/2/2024 | View on chart |
| QTRX | ▲ Buy | Grant | 16,102 | $0 | 1/6/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
QuidelOrtho Reports Q2 2026 Results and New IR Lead
QuidelOrtho released its second-quarter 2026 earnings, with reports noting that profit margins have recovered while cash levels remain a point of discussion. The company also announced the appointment of Sanjeev Sharma as Vice President of Investor Relations. These updates provide context for the stock's current position within its 52-week range.
QuidelOrtho Reports Q2 2026 Results and New IR Lead. QuidelOrtho released its second-quarter 2026 earnings, with reports noting that profit margins have recovered while cash levels remain a point of discussion. The company also announced the appointment of Sanjeev Sharma as Vice President of Investor Relations. These updates provide context for the stock's current position within its 52-week range.